ICICI Securities research report on Cera Sanitaryware
We recently interacted with management of Cera Sanitaryware (CRS). Takeaways: 1) Demand scenario in Q2-TD has seen some improvement QoQ but still remains sluggish. CRS expects stronger demand in H2FY25 as demand from projects has been healthy. It has maintained its guidance of single-digit YoY revenue growth for FY25. 2) Margins to remain ~16-17% in FY25 as the company has taken some price increases in Sep’24 which would negate RM increases. 3) Management has maintained its guidance of INR 29bn revenue (15.7% CAGR over FY24-27) with growth being driven by sanitaryware and faucetware segments. Maintain estimates and Jun’25E TP of INR 8,637, but upgrade the stock to HOLD from Reduce due to 16% stock price correction over the past 1 month.
Outlook
We believe CRS is well poised to benefit from the uptick in housing market due to its wide distribution, strong brand, comprehensive product portfolio and healthy balance sheet. Upgrade the stock to HOLD from Reduce due to 16% correction in stock price over the past 1 month with an unchanged Jun’25E TP of INR 8,637, set at an unchanged 35x Jun’26E PER.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.